This is exactly the type of opportunity that we could explore with the funds generated from a licensing deal with large pharma to ensure continue value creation from bisantrene long into the future.
This is exactly the type of opportunity that we could explore...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.86 |
Change
0.010(0.54%) |
Mkt cap ! $318.5M | |||
| Open | High | Low | Value | Volume |
| $1.85 | $1.89 | $1.85 | $63.37K | 33.99K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1800 | $1.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 780 | 2 |
View Market Depth
| Last trade - 14.44pm 17/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |